Overview of autologous stem cell transplantation.
There has been a dramatic increase in the number of autologous peripheral blood stem cell transplants over the last decade. Faster recovery of cell counts, lesser transplant morbidity, shorter hospital stay and reduced cost compared with marrow autografts have been the main advantages of autologous peripheral blood cell over marrow transplants. In this paper we attempt to review the advances in the biology and mobilization of stem cells, and focus on clinical results of autologous peripheral stem cell and marrow transplants for disease specific sites such as breast cancer, myeloma, autoimmune diseases, germ cell tumors, the acute and chronic leukemias, the non-Hodgkin's lymphomas and Hodgkin's disease. We also discuss transplant related complications, gene therapy and the different methods of purging. This review was intended for autologous peripheral stem cell transplants, however, unavoidably, it also discusses autologous marrow transplantation and aspects common to both procedures.
Saba
N
N
The University of Toronto Blood and Marrow Transplant Program, Ontario Cancer Institute/Princess Margaret Hospital, Ont., Toronto, Canada. nabil.saba@co.hennepin.mn.us
Abraham
R
R
Keating
A
A
D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000639:trends; D015316:Genetic Therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000639:trends*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011183:Postoperative Complications; D014182:Transplantation, Autologous / Q000009:adverse effects / Q000639:trends*